Abstract
Thirty to 50% of patients undergoing whole breast radiation therapy (WBRT) develop radiation dermatitis, yet the pathophysiology of this phenomenon is not fully understood. We sought to implement Cherenkoscopy, a novel system that visualizes superficial radiation dose in vivo and in real-time, during routine WBRT in order to compare the acquired images with treatment plans, predicted superficial dose (SD) and the development of adverse skin reactions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.